Chong W, Ibrahim N, Mohd-Said S
Case Rep Dent. 2025; 2025:8318894.
PMID: 39968166
PMC: 11835479.
DOI: 10.1155/crid/8318894.
Takeuchi R, Kuwahara N, Amino Y, Hayashi S, Taguchi C, Suzuki I
Diseases. 2024; 12(12.
PMID: 39727652
PMC: 11727098.
DOI: 10.3390/diseases12120322.
Takeuchi R, Nomura T, Yaguchi M, Kuwahara N, Amino Y, Taguchi C
PLoS One. 2024; 19(12):e0309189.
PMID: 39705288
PMC: 11661605.
DOI: 10.1371/journal.pone.0309189.
Takeuchi R, Nomura T, Yaguchi M, Taguchi C, Suzuki I, Suzuki H
Exp Ther Med. 2024; 28(1):297.
PMID: 38868612
PMC: 11168035.
DOI: 10.3892/etm.2024.12586.
Amititeloaie C, Chelaru L, Geletu G, Sava A, Jitareanu A, Tibeica A
Rom J Morphol Embryol. 2023; 64(1):35-40.
PMID: 37128789
PMC: 10257780.
DOI: 10.47162/RJME.64.1.04.
Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth.
Zhang R, Wu J, Zhu J, Wang X, Song J
Front Public Health. 2022; 10:979861.
PMID: 36148356
PMC: 9485543.
DOI: 10.3389/fpubh.2022.979861.
Transforming growth factor-β profile in cyclosporine-A induced gingival enlargement in renal transplant patients.
Abushama A, Ramadan A
Saudi Dent J. 2021; 33(2):85-89.
PMID: 33551621
PMC: 7848798.
DOI: 10.1016/j.sdentj.2020.01.004.
Factors affecting awareness and practice of primary health care professionals towards interaction of various medications used in systemic conditions, and its effect on periodontal health.
Sharma A, Sethi N, Sinha A, Gupta S, Sushil D, Sharma J
J Family Med Prim Care. 2020; 9(6):2969-2974.
PMID: 32984157
PMC: 7491786.
DOI: 10.4103/jfmpc.jfmpc_195_20.
Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth.
Gopinath S, Harishkumar V, Santhosh V, Puthalath S
J Indian Soc Periodontol. 2019; 23(4):377-380.
PMID: 31367138
PMC: 6628775.
DOI: 10.4103/jisp.jisp_557_18.
Gingival overgrowth: Part 1: aetiology and clinical diagnosis.
Beaumont J, Chesterman J, Kellett M, Durey K
Br Dent J. 2017; 222(2):85-91.
PMID: 28127024
DOI: 10.1038/sj.bdj.2017.71.
Oral pathology in inflammatory bowel disease.
Muhvic-Urek M, Tomac-Stojmenovic M, Mijandrusic-Sincic B
World J Gastroenterol. 2016; 22(25):5655-67.
PMID: 27433081
PMC: 4932203.
DOI: 10.3748/wjg.v22.i25.5655.
Immunoexpression of interleukin-6 in drug-induced gingival overgrowth patients.
Ganesh P
Contemp Clin Dent. 2016; 7(2):140-5.
PMID: 27307657
PMC: 4906853.
DOI: 10.4103/0976-237X.183048.
Propranolol-induced gingival hyperplasia with Nager syndrome: A rare adverse drug reaction.
Raheel S, Kujan O, Tarakji B, Umar D, Ibrahim S
J Adv Pharm Technol Res. 2016; 7(2):64-8.
PMID: 27144155
PMC: 4850771.
DOI: 10.4103/2231-4040.179749.
Defining periodontal health.
Mariotti A, Hefti A
BMC Oral Health. 2015; 15 Suppl 1:S6.
PMID: 26390888
PMC: 4580771.
DOI: 10.1186/1472-6831-15-S1-S6.
Multidrug resistance 1 gene polymorphism in amlodipine-induced gingival enlargement.
Naik K, Jhajharia K, Chaudhary R, Tatikonda A, Dhaliwal A, Kaur R
J Indian Soc Periodontol. 2015; 19(2):239-41.
PMID: 26015682
PMC: 4439641.
DOI: 10.4103/0972-124X.145837.
Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice.
Assaggaf M, Kantarci A, Sume S, Trackman P
Am J Pathol. 2015; 185(6):1588-99.
PMID: 25843680
PMC: 4450317.
DOI: 10.1016/j.ajpath.2015.02.004.
Molecular and clinical aspects of drug-induced gingival overgrowth.
Trackman P, Kantarci A
J Dent Res. 2015; 94(4):540-6.
PMID: 25680368
PMC: 4485217.
DOI: 10.1177/0022034515571265.
Sodium valproate induced gingival enlargement in 22 months old child.
Dhalkari C, Ganatra P
J Indian Soc Periodontol. 2014; 18(5):644-7.
PMID: 25425829
PMC: 4239757.
DOI: 10.4103/0972-124X.142465.
Drugs, medications and periodontal disease.
Heasman P, Hughes F
Br Dent J. 2014; 217(8):411-9.
PMID: 25342347
DOI: 10.1038/sj.bdj.2014.905.
Speech intelligibility after gingivectomy of excess palatal tissue.
Balasundaram A, Vinayagavel M, Bandi D
Contemp Clin Dent. 2014; 5(3):406-9.
PMID: 25191084
PMC: 4147824.
DOI: 10.4103/0976-237X.137974.
